The Gamma Knife Brain Radiosurgery Department is unique in Greece and the only center to use the advanced Gamma Knife Perfexion system in the country.
It works in cooperation with Hygeia’s Radiation Oncology Center, and together they constitute a center of excellence for Elekta, the company that developed the Leksell Gamma Knife.
Gamma Knife radiosurgery is a globally recognized non-invasive treatment used in more than 200 hospitals worldwide, treating about 50,000 patients annually:
- Delivering highly accurate, high-dose radiation to small intracranial targets without affecting surrounding tissue, requiring only local anesthesia
- Allowing patients to return to normal activities the next day.
- Specially suitable for pediatric tumors due to minimal exposure of healthy brain tissue.
- With over 70,000 documented cases in peer-reviewed studies, it is the most clinically validated method in its field.
- The technique damages the DNA of targeted cells, leading to their gradual elimination, and may be used alone or combined with other therapies.
- Given the rising incidence of cancer and brain metastases, the Gamma Knife is expected to play an increasingly significant role in future healthcare.
Director: Dr. Konstantinos Lampropoulos, Neurosurgeon
Dr. Konstantinos Lampropoulos is a board-certified neurosurgeon and Head of the Gamma Knife Brain Radiosurgery Department, with extensive clinical and academic experience in cranial, spinal, functional and stereotactic neurosurgery. He is a graduate of the Medical School of the University of Crete and holds a PhD focused on the surgical treatment of pituitary adenomas.
His professional background includes long-standing training and practice in major neurosurgical and radiosurgical centers in Greece, with continuous service at Hygeia Hospital since 2012 and current appointment as Consultant Neurosurgeon.
His clinical expertise spans brain and spinal cord tumor microsurgery, skull base surgery, functional and stereotactic neurosurgery, Gamma Knife radiosurgery, spine surgery, and neuroendocrine disorders, with a particular focus on pituitary tumors. He maintains an active research profile in stereotactic radiosurgery, neuronavigation and minimally invasive spine surgery, with publications in peer-reviewed international journals. He is an active member of international scientific societies related to stereotactic radiosurgery.